BIPOC-owned LaPlace Interventional is developing a transcatheter tricuspid valve replacement device designed for delivery through a simple, minimally invasive procedure to reduce future complications in patients.
The company was founded by former Caisson Interventional R&D senior director Ramji Iyer, who led Caisson’s transcatheter mitral valve program. (LivaNova acquired Caisson for $72 million in 2017, only to end its transcatheter mitral valve replacement (TMVR) program two years later.)
Iyer has more than 10 years of heart valve development experience with over 20 patents and 10 scientific publications. He holds a master’s and Ph.D. in mechanical engineering from the University of Minnesota.